Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
965.26M | 1.22B | 1.34B | 1.21B | 897.02M | Gross Profit |
9.72M | 15.65M | -27.55M | 67.78M | 52.86M | EBIT |
-51.67M | -23.85M | -61.36M | 16.52M | -18.60M | EBITDA |
-51.67M | 2.60M | -12.75M | 61.89M | 51.15M | Net Income Common Stockholders |
-60.25M | -28.00M | -41.60M | 46.08M | -17.28M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
35.47M | 30.01M | 36.46M | 50.61M | 47.67M | Total Assets |
401.44M | 454.24M | 478.32M | 484.95M | 476.82M | Total Debt |
4.85M | 105.46M | 87.27M | 63.65M | 108.23M | Net Debt |
4.85M | 75.44M | 50.81M | 13.04M | 60.57M | Total Liabilities |
176.38M | 174.68M | 170.23M | 139.74M | 180.58M | Stockholders Equity |
225.06M | 279.56M | 308.09M | 345.21M | 296.24M |
Cash Flow | Free Cash Flow | |||
-14.59M | -7.51M | -31.70M | 10.44M | 65.20M | Operating Cash Flow |
-3.52M | 22.02M | 6.05M | 26.82M | 71.78M | Investing Cash Flow |
-13.47M | -33.03M | -37.66M | 27.12M | 23.32M | Financing Cash Flow |
7.72M | 6.96M | 19.01M | -40.00M | -66.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $706.84M | 12.75 | 10.83% | ― | -23.12% | -4.89% | |
65 Neutral | $607.71M | 26.52 | 5.08% | 0.95% | -4.09% | -66.97% | |
50 Neutral | $1.98B | -1.07 | -21.34% | 3.71% | 2.03% | -30.65% | |
49 Neutral | $289.72M | ― | -12.34% | ― | -19.82% | -34.91% | |
48 Neutral | $258.73M | ― | -16.11% | ― | 145.38% | -22.02% | |
42 Neutral | $92.69M | ― | 103.25% | 1.51% | -5.28% | 51.91% | |
37 Underperform | $69.51M | ― | -24.43% | ― | -17.27% | -112.62% |
On March 17, 2025, Alto Ingredients, Inc. entered into a letter agreement with the Radoff/Torok Group, which includes provisions for board member nominations and standstill agreements. As part of this agreement, board members Douglas L. Kieta and Michael D. Kandris announced they would not stand for re-election at the 2025 Annual Meeting, impacting the company’s board composition and governance structure.